Japan - Healthcare, Regulatory and Reimbursement Landscape

Japan - Healthcare, Regulatory and Reimbursement Landscape

Summary

The industry analysis specialist, has released its latest report, "Japan - Healthcare, Regulatory and Reimbursement Landscape". The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Japan. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

The Japanese pharmaceutical market is the third largest in the world in terms of value. Japan’s pharmaceutical market, based on production value, increased from ¥6,894B in 2013 to ¥9,281B in 2020 at a Compound Annual Growth Rate (CAGR) of 4.34%. In terms of US Dollars, the market increased from $70.64B in 2013 to $86.96B in 2020 at a CAGR of 3.01%. It is forecast to reach about $100.88B in 2025. The increasing elderly population, chronic and lifestyle diseases, incentives for innovation, and short regulatory approval timelines are the main factors driving the growth of the Japanese pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Japan, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, Takeda, and Astellas Pharma
Profiles and SWOT analyses of the major players in the medical device market: Medtronic, Siemens Healthineers, DePuy Synthes, Olympus, and Terumo
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Japanese healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving Japan’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact Japan’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary
2.2 Key Highlights - Facts about the Japanese Healthcare Market
2.3 Key Highlights: Healthcare Startups in Japan
2.4 Key Events: Japanese Healthcare Timeline, 2014-2020
2.5 Key Events: Japanese Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Japan, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Exports
3.3 Pharmaceutical Market - Imports
3.4 Pharmaceutical Market - Supply Channels, Japan
3.5 Pharmaceutical Market - Market Segments
3.6 Major Therapeutic Areas, Japan
3.7 COVID-19 Epidemiology, Japan
3.8 COVID-19 Impact and Developments in the Healthcare Market, Japan
3.9 COVID-19 Clinical Trials Landscape, Japan
3.10 Pharmaceutical Market - Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market - Overview
4.2 Medical Devices Market - Major Players

5. Pharmaceutical and Medical Devices Market - Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Japan, 2020-2021
6.2 Deal Analysis: Medical Device Market, Japan, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Japan
7.2 HealthTech Deals Landscape, Japan
7.3 Key HealthTech Deals, Japan
7.4 Adoption of Technology in Healthcare, Japan
7.5 Key Development Technologies, Japan
7.6 Regulatory Scenario Covering Use of Technology in Healthcare, Japan
7.7 HealthTech Landscape: Benefits and Risks, Japan

8. Market Access

8.1 Overview of Healthcare System, Japan
8.2 Reimbursement Process, Japan
8.3 Overview of Insurance Providers, Japan
8.4 Healthcare Spending and Prescription Drug Price Trend, Japan
8.5 Pricing Policies, Japan
8.6 Regulatory Landscape, Japan
8.6.1 Overview of Regulatory Agencies
8.6.2 Marketing Authorization for Pharmaceutical Products, Japan
8.6.3 Marketing Authorization for Medical Devices, Japan
8.6.4 Marketing Authorization for Regenerative Medical Products, Japan
8.6.5 Intellectual Property Rights, Patent, Japan
8.6.6 Intellectual Property Rights, Trademark, Japan
8.6.7 Clinical Trial Regulation Process, Japan
8.6.8 Pharmaceutical Clinical Trials Landscape, Japan
8.6.9 Medical Devices Clinical Trials Landscape, Japan
8.6.10 Market Authorization for Pharmaceutical Manufacturing, Japan
8.6.11 Market Authorization for Medical Devices Manufacturing, Japan
8.6.10 Pharmaceutical Export and Import, Japan
8.6.13 Pharmaceutical Advertisement Regulations, Japan
8.6.14 Pharmacy Regulations, Japan
8.6.15 Labeling and Packaging Regulations, Japan

9. Country Healthcare Landscape

9.1 Japanese Healthcare Policy Highlights
9.2 Healthcare Facilities, Japan
9.3 Healthcare Parameters, Japan
9.4 Life Expectancy and Immunization Rate, Japan
9.5 Environmental Health, Japan
9.6 Healthcare Personnel, Japan
9.7 Disease Burden, Japan
9.8 Healthcare Expenditure, Japan
10 Trade Associations, Japan
11 Trade Fairs, Japan
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact the Publisher
13.5 Disclaimer

List of Tables

Table 1: Biopharmaceuticals Composition Ratio (%), Japan, 2019
Table 2: Approved Biosimilars, Japan, 2017-2021
Table 3: Major Therapeutic Areas by Production Value ($B), Japan, 2019
Table 4: COVID-19 Indicators (Number of Cases), Global and Japan, 2020-2021
Table 5: COVID-19-Related Travel Restrictions, Japan, 2020-2021
Table 6: COVID-19 Vaccines Development Landscape, Japan, 2020-2021
Table 7: Approved Medical Products for COVID-19, Japan, 2020-2021
Table 8: Approved Medical Devices for COVID-19, Japan, 2020-2021
Table 9: COVID-19 IVD Products (April ‘20- April ‘21), Japan, 2020-2021
Table 10: Medical Device Market, Japan, Major Segments ($B), 2020
Table 11: General Surgery Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 12: Orthopedic Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 13: Cardiovascular Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 14: Wound Care Management Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 15: Nephrology and Urology Devices Market, Japan, Revenue ($M) and Market Share (%) of Major Companies, 2019
Table 16: Medical Device Reimbursement Assessment Categories, Japan, 2018
Table 17: Public Insurance Schemes, Japan, 2019
Table 18: Types of Premiums, Japan, 2020
Table 19: Classification and Regulation Regarding Medical Devices, Japan, 2021
Table 20: Classification of Regenerative Medical Products, Japan, 2021
Table 21: Patent Fees, Japan, 2021
Table 22: Trademark Fees, Japan, 2021
Table 23: Headings and their Sequence in Package Inserts, Japan, 2021

List of Figures

Figure 1: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 2: Medical Device Market, Japan, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Japan, 2021
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Japan, 2020
Figure 7: Pharmaceutical Market, Japan, Revenue ($B and ¥B), 2013-2020
Figure 8: Pharmaceutical Market, Japan, Revenue Forecast ($B and ¥B), 2021-2025
Figure 9: AMED Projects, Japan, 2019
Figure 10: Pharmaceutical Exports ($B), Japan, 2013-2020
Figure 11: Top Export Partners, Japan, 2020
Figure 12: Pharmaceutical Imports ($B), Japan, 2013-2020
Figure 13: Top Import Partners, Japan, 2020
Figure 14: Pharmaceutical Supply Channel, Japan, 2021
Figure 15: Generic Drugs Penetration Rate, Japan, 2005-2018
Figure 16: Pharmaceutical, Biotechnology, and Healthcare Clusters, Japan, 2021
Figure 17: OTC Medicines Market, Revenue ($B), Japan, 2013-2020
Figure 18: OTC Medicines Market, Major Distribution Channels ($B), Japan, 2020
Figure 19: OTC Medicines Market, Major Categories ($B), Japan, 2020
Figure 20: Major Therapeutic Areas by Production Value, Japan, 2019
Figure 21: COVID-19 Cases, Japan, 2020-2021
Figure 22: COVID-19 Deaths, Japan, 2020-2021
Figure 23: COVID-19 Fiscal Stimulus Timeline, Japan, 2020-2021
Figure 24: COVID-19 Vaccination Progress, Japan, 2021
Figure 25: COVID-19 Clinical Trials Count by Phase, Japan, 2020-2021
Figure 26: COVID-19 Clinical Trials Count by Trial Status, Japan, 2020-2021
Figure 27: Top Five COVID-19 Clinical Trials Sponsors by Trial Count, Japan, 2020-2021
Figure 28: Medical Devices Market, Japan, Revenue ($B), 2015-2020
Figure 29: Medical Devices Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 30: AMED Projects for Medical Device, Japan, 2020
Figure 31: Medical Device Market, Japan, Major Segments (%), 2020
Figure 32: General Surgery Market, Japan, Revenue ($B), 2017-2025
Figure 33: General Surgery Market, Japan, Market Share of Major Players (%), 2019
Figure 34: Orthopedic Devices Market, Japan, Revenue ($B), 2017-2025
Figure 35: Orthopedic Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 36: Cardiovascular Devices Market, Japan, Revenue ($B), 2017-2025
Figure 37: Cardiovascular Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 38: Wound Care Management Market, Japan, Revenue ($B), 2017-2025
Figure 39: Wound Care Management Market, Japan, Market Share of Major Players (%), 2019
Figure 40: Nephrology and Urology Devices Market, Japan, Revenue ($B), 2017-2025
Figure 41: Nephrology and Urology Devices Market, Japan, Market Share of Major Players (%), 2019
Figure 42: Diagnostics Market, Japan, Revenue ($B), 2015-2020
Figure 43: Diagnostics Market, Japan, Revenue Forecast ($B), 2021-2025
Figure 44: Medical Devices Market, Revenue ($B) of Major Companies, Japan, 2019
Figure 45: Deal Value and Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 46: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Japan, 2020-2021
Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Japan, 2020-2021
Figure 48: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Japan, 2020-2021
Figure 49: Top Five Therapy Areas by Deal Count, Pharmaceutical Market, Japan, 2020-2021
Figure 50: M&A Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 51: VC Deals by Therapy Area, Pharmaceutical Market, Japan, 2020-2021 (by Value ($M) and by Number)
Figure 52: Medical Devices Market Deals by Deal Value ($M), Japan, 2020-2021
Figure 53: Medical Devices Market Deals by Deal Count, Japan, 2020-2021
Figure 54: Medical Devices Market Deals Share by Deal Value, Japan, 2020-2021
Figure 55: Medical Devices Market Deals Share by Deal Count, Japan, 2020-2021

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1971EUR$1,995USD£1,641GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3942EUR$3,990USD£3,281GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5914EUR$5,985USD£4,922GBP

Table of Contents

Related Topics

Related Reports

Chronic Disease Management: Therapeutics, Device Technologies and Global Markets

Healthcare Reimbursement Global Market Report 2024

Healthcare BPO Market Report by Payer Service, Provider Service, Pharmaceutical Service, and Region 2024-2032

Healthcare Reimbursement Market by Claim, Payer, Service Provider - Global Forecast 2025-2030

Disease Management Apps Global Market Report 2024